Everbridge (NASDAQ:EVBG) Price Target Raised to $115.00

Share on StockTwits

Everbridge (NASDAQ:EVBG) had its price objective increased by SunTrust Banks from $100.00 to $115.00 in a research note published on Wednesday morning, BenzingaRatingsTable reports. SunTrust Banks currently has a buy rating on the technology company’s stock.

A number of other brokerages also recently weighed in on EVBG. Northland Securities reiterated a buy rating and issued a $99.00 price objective on shares of Everbridge in a research report on Tuesday, November 5th. Canaccord Genuity reissued a buy rating and set a $105.00 target price (up from $90.00) on shares of Everbridge in a research note on Wednesday. Credit Suisse Group raised their target price on Everbridge from $90.00 to $95.00 and gave the company an outperform rating in a research report on Wednesday. Zacks Investment Research lowered Everbridge from a buy rating to a hold rating in a research note on Thursday, January 30th. Finally, Oppenheimer initiated coverage on Everbridge in a report on Tuesday, January 7th. They issued a hold rating for the company. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Everbridge presently has a consensus rating of Buy and a consensus price target of $103.08.

NASDAQ:EVBG opened at $104.97 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.76 and a quick ratio of 1.76. The company has a 50 day moving average price of $89.53 and a 200-day moving average price of $80.51. Everbridge has a 1-year low of $59.85 and a 1-year high of $105.99. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of -66.02 and a beta of 0.91.

Everbridge (NASDAQ:EVBG) last announced its quarterly earnings results on Tuesday, February 18th. The technology company reported $0.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.01. The firm had revenue of $57.11 million for the quarter, compared to the consensus estimate of $56.21 million. Everbridge had a negative net margin of 26.01% and a negative return on equity of 20.87%. The firm’s quarterly revenue was up 36.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.09) earnings per share. On average, sell-side analysts anticipate that Everbridge will post -2.15 earnings per share for the current fiscal year.

In other news, SVP Elliot J. Mark sold 3,500 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $78.11, for a total transaction of $273,385.00. Following the completion of the sale, the senior vice president now owns 9,624 shares of the company’s stock, valued at $751,730.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Phillip E. Huff sold 762 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $86.50, for a total transaction of $65,913.00. Following the sale, the chief accounting officer now directly owns 4,473 shares of the company’s stock, valued at approximately $386,914.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 136,972 shares of company stock worth $12,181,737. Insiders own 2.20% of the company’s stock.

A number of hedge funds have recently bought and sold shares of EVBG. Select Equity Group L.P. increased its stake in Everbridge by 217.1% during the 3rd quarter. Select Equity Group L.P. now owns 2,669,506 shares of the technology company’s stock worth $164,735,000 after buying an additional 1,827,525 shares in the last quarter. BlackRock Inc. lifted its position in shares of Everbridge by 29.5% in the second quarter. BlackRock Inc. now owns 2,596,838 shares of the technology company’s stock valued at $232,209,000 after acquiring an additional 591,681 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Everbridge by 2.2% in the fourth quarter. Bank of New York Mellon Corp now owns 1,935,075 shares of the technology company’s stock valued at $151,090,000 after acquiring an additional 41,549 shares in the last quarter. Sylebra Capital Ltd lifted its position in shares of Everbridge by 55.8% in the fourth quarter. Sylebra Capital Ltd now owns 1,337,148 shares of the technology company’s stock valued at $104,405,000 after acquiring an additional 478,726 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Everbridge by 20.5% in the fourth quarter. Alliancebernstein L.P. now owns 846,769 shares of the technology company’s stock worth $66,116,000 after acquiring an additional 144,285 shares during the last quarter.

About Everbridge

Everbridge, Inc operates as a software company in the United States and internationally. The company's Critical Event Management, a software as a service based platform with various software applications that address tasks an organization has to perform to manage a critical event, including Mass Notification that enables enterprises and governmental entities to send notifications to individuals or groups to keep them informed before, during, and after natural or man-made disasters, and other emergencies; Safety Connection that enables organizations to send notifications based on last known location of an individual; Incident Management that enables organizations to automate workflows and make their communications relevant; and IT Alerting that enables IT professionals to alert and communicate with members of their teams during an IT incident or outage.

Featured Article: Municipal Bonds

Analyst Recommendations for Everbridge (NASDAQ:EVBG)

Receive News & Ratings for Everbridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everbridge and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.